Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Clinical trial NCT07402915 · RECRUITING

Trial details

NCT number: NCT07402915
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal

Start date: 2026-01-26
Primary completion: 2027-10-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.